NO973422D0 - Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor - Google Patents

Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor

Info

Publication number
NO973422D0
NO973422D0 NO973422A NO973422A NO973422D0 NO 973422 D0 NO973422 D0 NO 973422D0 NO 973422 A NO973422 A NO 973422A NO 973422 A NO973422 A NO 973422A NO 973422 D0 NO973422 D0 NO 973422D0
Authority
NO
Norway
Prior art keywords
receptor
agonists
antagonists
recombinant
nucleic acids
Prior art date
Application number
NO973422A
Other languages
Norwegian (no)
Other versions
NO973422L (en
Inventor
Johan Sundelin
Robert M Scarborough
Original Assignee
Cor Therapautics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cor Therapautics Inc filed Critical Cor Therapautics Inc
Publication of NO973422D0 publication Critical patent/NO973422D0/en
Publication of NO973422L publication Critical patent/NO973422L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO973422A 1995-01-25 1997-07-24 Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor NO973422L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39030195A 1995-01-25 1995-01-25
PCT/US1996/001179 WO1996023225A1 (en) 1995-01-25 1996-01-25 Recombinant c140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor

Publications (2)

Publication Number Publication Date
NO973422D0 true NO973422D0 (en) 1997-07-24
NO973422L NO973422L (en) 1997-09-24

Family

ID=23541929

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973422A NO973422L (en) 1995-01-25 1997-07-24 Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor

Country Status (7)

Country Link
EP (1) EP0870198A4 (en)
JP (1) JPH11514207A (en)
KR (1) KR19980701637A (en)
CA (1) CA2211176A1 (en)
NO (1) NO973422L (en)
NZ (2) NZ302524A (en)
WO (1) WO1996023225A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9620028D0 (en) 1996-09-26 1996-11-13 Ludwig Inst Cancer Res Factors which interact with oncoproteins
US6737252B2 (en) 1997-07-25 2004-05-18 Schering Corporation 7 transmembrane receptor family member BLRX
US6984719B1 (en) 1998-09-17 2006-01-10 Hospital Sainte-Justine Peptide antagonists of prostaglandin F2α receptor
JP4431280B2 (en) 1998-09-17 2010-03-10 オピタル・サント−ジュスティーヌ G protein-coupled receptor agonist or antagonist
ATE298346T1 (en) 1999-12-06 2005-07-15 Chu Sainte Justine COMPOUNDS FOR THE TREATMENT OF ABNORMAL GLOMERULAR FILTRATION, PATENT DUCTUS ARTERIOSUS AND OSTEOPOROSIS
US7214655B2 (en) * 2001-05-21 2007-05-08 Johnson & Johnson Consumer Companies, Inc. Peptides and the use thereof in darkening the skin
US7521530B2 (en) 2002-06-11 2009-04-21 Universite De Montreal Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2α receptor
JP4927566B2 (en) 2004-12-28 2012-05-09 興和株式会社 PAR-2 agonist
US8133864B2 (en) 2005-03-29 2012-03-13 Kowa Company, Ltd. PAR-2 agonist
FR2883873B1 (en) 2005-03-31 2009-07-10 Pharmamens Sarl AGE INHIBITORS
AR070911A1 (en) * 2008-03-19 2010-05-12 Regeneron Pharma USE OF PARTA RECEPTOR ANTAGONISTS ACTIVATED WITH PROTEASA

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629174A (en) * 1993-07-26 1997-05-13 Cor Therapeutics, Inc. Recombinant C140 receptor

Also Published As

Publication number Publication date
NZ302524A (en) 1999-05-28
CA2211176A1 (en) 1996-08-01
JPH11514207A (en) 1999-12-07
WO1996023225A1 (en) 1996-08-01
KR19980701637A (en) 1998-06-25
EP0870198A1 (en) 1998-10-14
NO973422L (en) 1997-09-24
NZ334998A (en) 2000-11-24
EP0870198A4 (en) 2001-04-04

Similar Documents

Publication Publication Date Title
TR199801594A3 (en) CCR-3 receptor antagonists.
DE69734833D1 (en) VITRONEKTIN RECEPTOR ANTAGONISTS
DE69812096D1 (en) NEUROPEPTID Y RECEPTOR ANTAGONISTS
NO972016D0 (en) Indolyl-Y receptor antagonists
NO996178D0 (en) 4-Aminopyrrole (3,2-d) pyrimidines as neuropeptide γ receptor antagonists
DK1009732T3 (en) 1-Amino-alkylcyclohexane NMDA receptor antagonists
NO986110D0 (en) IL-8 receptor antagonists
NO986109D0 (en) IL-8 receptor antagonists
FI961804A (en) endothelin receptor antagonists
DK0733626T3 (en) N- (Benzofurazanyl) -arylsulfonamides and analogs thereof which can be used as endothelin receptor antagonists
NO990668D0 (en) IL-8 receptor antagonists
TR199600359A2 (en) Adhesion receptor antagonists.
BR9406572A (en) Endothelin receptor antagonists
ID24726A (en) TROMBIN RECEPTOR ANTAGONISTS
NO950606D0 (en) Adhesion receptor antagonists
KR960700722A (en) Fibrinogen receptor antagonists
ID24162A (en) VITRONECTTIN RECEPTOR ANTAGONISTS
NO973422D0 (en) Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor
DK0906294T3 (en) Benzoxazinone-dopamine D4 receptor antagonists
FI970823A (en) Novel peptide derivatives with delta-opioid receptor antagonist effects or concomitant my-agonist / delta-antagonist effects
TR199501389A2 (en) Adesion receptor antagonists (counterparts).
DZ2322A1 (en) Vitronectin receptor antagonists.
DE69513832T2 (en) EXCITATIVE AMINO ACID RECEPTOR ANTAGONISTS
ITMO960144A0 (en) POLISHING-SMOOTHING MACHINE FOR SLABS, TILES AND THE SIMILAR
NO20021614L (en) DNA encoding PROST 07 polypeptide

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application